Article

The benefits, harms, and cost-effectiveness of age-based and risk-stratified screening for prostate cancer with MRI

2025-12-02

Abstract excerpt

<h4>Background</h4> Prostate cancer screening remains contested. MRI-first screening may reduce overdiagnosis by detecting fewer insignificant cancers than PSA-first strategies. However, the benefits, harms, and cost-effectiveness of MRI-first prostate cancer screening remains uncertain. <h4>Methods</h4> We simulated age-based and risk-stratified MRI-first screening strategies. Risk-stratification involved eithe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 66fe052f-ee39-5d93-92ca-29a89a527f33
DOI: 10.64898/2025.11.28.25341221

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The benefits, harms, and cost-effectiveness of age-based and risk-stratified screening for prostate cancer with MRIDOI 10.64898/2025.11.28.25341221Read

Systematic Review of cost-effectiveness models in prostate cancer: exploring new developments in testing and diagnosisSemantic proximity Read

Screening for prostate cancer using PSA with and without MRI: systematic reviews with meta-analysisSemantic proximity Read

Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms.Semantic proximity Read

Optimizing Detection of Clinically Significant Prostate Cancer through Nomograms incorporating MRI, Clinical Features, and Advanced Serum BiomarkersSemantic proximity Read

Assessment of a Polygenic Risk Score in Screening for Prostate CancerSemantic proximity Read

Impact of a new diagnostic pathway for prostate cancer - From systematic transrectal to targeted MRI fusion transperineal biopsiesSemantic proximity Read

MRI-Targeted Prostate Biopsy Introduces Grade Inflation and OvertreatmentSemantic proximity Read

The role of prophylactic prostatectomy as a primary prevention strategy in high-risk germline mutation carriers.Semantic proximity Read

Magnetic Resonance Imaging-based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prostate Cancer Genetic Risk Evaluation and Screening Study.Semantic proximity Read

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.Semantic proximity Read

Risk stratification in men with a negative prostate biopsy: an interim analysis of a prospective cohort study.Semantic proximity Read

Report prepared for the Health Technology Assessment panel of the NHS Executive on the diagnosis, management, treatment and costs of prostate cancer in England and Wales.Semantic proximity Read